Gregory Friess
Hematology & Oncology · Fort Worth, TXNPI 1952351736
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.
Across 46 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$116
- Lilly USA, LLC$108
- Teva Pharmaceuticals USA, Inc.$79
- Verastem, Inc.$74
- E.r. Squibb & Sons, L.L.C.$59
- Tersera Therapeutics LLC$55
- plus $485 from 16 others
What the payments were for
- Food & beverage$977100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $116 |
| Lilly USA, LLC | 7 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $79 |
| Verastem, Inc. | 3 | $74 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Tersera Therapeutics LLC | 2 | $55 |
| Puma Biotechnology, Inc. | 3 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Amgen | 2 | $44 |
| Novartis | 3 | $42 |
| Exelixis Inc. | 1 | $38 |
| Bayer | 2 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Seagen Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Gilead | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $24 |
| Array Biopharma Inc | 2 | $24 |
| Johnson & Johnson | 1 | $21 |
| Bristol Myers Squibb | 1 | $17 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$102
How this compares
$977 in reported general payments places this provider in the 30th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in Fort Worth
- Asad DeanFort Worth$1.1M
- Jeremy RossFort Worth$520K
- Prasanthi GanesaFort Worth$205K
- Asim AhmadFort Worth$130K
- Harris NainaFort Worth$115K
- Devesh PandyaHouston$1.8M
- Elias JabbourHouston$1.3M
- Habte YimerTyler$934K
- Edward PearsonDallas$900K
- Naval DaverHouston$853K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.